Reports- Cancer Immunotherapy Market Trends | Page 3

5 United States Cancer Immunotherapy Sales (Volume) by Application (2011-2016)
5.1 United States Cancer Immunotherapy Sales and Market Share by Application (2011-2016)
5.2 United States Cancer Immunotherapy Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities
6 United States Cancer Immunotherapy Manufacturers Profiles/Analysis
6.1 Amgen
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Cancer Immunotherapy Product Type, Application and Specification
6.1.2.1 Melanoma
6.1.2.2 Colorectal cancer
6.1.3 Amgen Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
6.1.4 Main Business/Business Overview
6.2 AstraZeneca
6.2.2 Cancer Immunotherapy Product Type, Application and Specification
6.2.2.1 Melanoma
6.2.2.2 Colorectal cancer
6.2.3 AstraZeneca Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
6.2.4 Main Business/Business Overview
6.3 F. Hoffman La-Roche
6.3.2 Cancer Immunotherapy Product Type, Application and Specification
6.3.2.1 Melanoma
6.3.2.2 Colorectal cancer
6.3.3 F. Hoffman La-Roche Cancer Immunotherapy Sales, Revenue, Price and Gross Margin
(2011-2016)
6.3.4 Main Business/Business Overview
6.4 Bayer AG
6.4.2 Cancer Immunotherapy Product Type, Application and Specification
6.4.2.1 Melanoma
6.4.2.2 Colorectal cancer
6.4.3 Bayer AG Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
6.4.4 Main Business/Business Overview
6.5 Bristol-Myers Squibb
6.5.2 Cancer Immunotherapy Product Type, Application and Specification
6.5.2.1 Melanoma
6.5.2.2 Colorectal cancer
6.5.3 Bristol-Myers Squibb Cancer Immunotherapy Sales, Revenue, Price and Gross Margin
(2011-2016)
6.5.4 Main Business/Business Overview
6.6 Eli Lilly and Company
6.6.2 Cancer Immunotherapy Product Type, Application and Specification
6.6.2.1 Melanoma